Last reviewed · How we verify
NCT04912934: COVID-19
The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome
trial testing A survey form was applied to individuals included in the study face-to-face. in Metabolic Syndrome in 214 participants. Completed in 12 December 2020.
20 November 2020
Quick facts
| Lead sponsor | Ordu University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 214 |
| Start date | 20 June 2020 |
| Primary completion | 20 November 2020 |
| Estimated completion | 12 December 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- A survey form was applied to individuals included in the study face-to-face.
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Emotional Eating — all drugs for Emotional Eating →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Ordu University
Who can join
Adults 18 to 70, any sex, with Metabolic Syndrome or Emotional Eating. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04912934
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Ordu University trials
Trials by the same sponsor.
- NCT07527676 — Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes · not yet recruiting
- NCT07504874 — The Effect of Gardening Activities on the Quality of Life of Students With Mild Intellectual Disability · NA · not yet recruiting
- NCT07500402 — THE EFFECT OF GARDENING ON PSYCHOLOGICAL WELL-BEING AND CARE AMONG NURSING HOME CARE STAFF · NA · not yet recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07457268 — Effect of Transcutaneous Auricular Trigeminal Nerve Stimulation on Migraine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04912934 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ordu University
- Last refreshed: 3 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04912934.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing